SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001305227-14-000171
Filing Date
2014-02-11
Accepted
2014-02-11 15:27:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 cumberland.pharmaceuticals.txt SC 13G/A 10281
  Complete submission text file 0001305227-14-000171.txt   11980
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-85205 | Film No.: 14593967
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 EAST 52ND STREET NEW YORK NY 10022
Business Address 40 EAST 52ND STREET NEW YORK NY 10022 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

IRS No.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies